Several challenges can complicate the compassionate use process:
- Limited Supply: Manufacturers may have limited quantities of investigational drugs. - Regulatory Hurdles: The approval process can be time-consuming. - Cost: These programs can be expensive, and not all costs may be covered by insurance.
